Company
Neumann prepared this survey to learn what clinicians are thinking about the approaching era of HPV screening as part of cervical cancer prevention and its potential benefits.
Neumann will be present at the 31st International Papillomavirus Conference to be held at Cape Town, South Africa.
+++CHOICE CONTENTS +++ Recommended by IJC Editors: "Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women", by Kocsis, A. et al.
Neumann will be present at EUROGIN 2016 in Salzburg, Austria.
GenomeWeb published an in-depth article on NEUMANN, about the company's products and plans.
Disclaimer
© 2023 Neumann Diagnostics Ltd.
